Incidental abdominal computed tomography findings in patients newly diagnosed with Philadelphia-negative myeloproliferative neoplasm.
作者信息
Song Ik-Chan, Koh Jeong Suk, Kang Sora, Lee Myung-Won, Shin Kyung Sook, Jo Deog-Yeon
机构信息
Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
出版信息
Blood Res. 2023 Dec 31;58(4):221-224. doi: 10.5045/br.2023.2023049. Epub 2023 Oct 19.
Abstract
摘要
相似文献
1
Incidental abdominal computed tomography findings in patients newly diagnosed with Philadelphia-negative myeloproliferative neoplasm.
Blood Res. 2023 Dec 31;58(4):221-224. doi: 10.5045/br.2023.2023049. Epub 2023 Oct 19.
2
[Two myeloproliferative diseases in one patient - co-occurence of clones].
Orv Hetil. 2022 Jul 10;163(28):1123-1129. doi: 10.1556/650.2022.32516.
3
Emerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis.
Expert Opin Investig Drugs. 2013 Dec;22(12):1603-11. doi: 10.1517/13543784.2013.832199. Epub 2013 Sep 25.
4
Clinical and Payer-Based Analysis of Value of Dual-Energy Computed Tomography for Workup of Incidental Abdominal Findings.
J Comput Assist Tomogr. 2019 Jul/Aug;43(4):605-611. doi: 10.1097/RCT.0000000000000886.
5
3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Mod Pathol. 2017 Jul;30(7):940-951. doi: 10.1038/modpathol.2017.19. Epub 2017 Mar 24.
6
Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.
Ann Hematol. 2016 Oct;95(10):1611-6. doi: 10.1007/s00277-016-2765-0. Epub 2016 Jul 29.
7
Thrombin generation - a potentially useful biomarker of thrombotic risk in Philadelphia-negative myeloproliferative neoplasms.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Mar;161(1):50-53. doi: 10.5507/bp.2016.064. Epub 2017 Jan 6.
8
CCL2 rs1024611Gene Polymorphism in Philadelphia-Negative Myeloproliferative Neoplasms.
Genes (Basel). 2022 Mar 10;13(3):492. doi: 10.3390/genes13030492.
9
Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.
Afr Health Sci. 2014 Dec;14(4):1069-73. doi: 10.4314/ahs.v14i4.39.
10
Prevalence of incidental findings on abdominal computed tomography angiograms on prospective renal donors.
Transplantation. 2015 Jun;99(6):1203-7. doi: 10.1097/TP.0000000000000486.
本文引用的文献
1
Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms.
Intern Med. 2022 Dec 1;61(23):3483-3490. doi: 10.2169/internalmedicine.9124-21. Epub 2022 May 7.
2
Volumetric Splenomegaly in Patients With Polycythemia Vera.
J Korean Med Sci. 2022 Mar 21;37(11):e87. doi: 10.3346/jkms.2022.37.e87.
3
Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm.
Blood Res. 2022 Mar 31;57(1):59-68. doi: 10.5045/br.2021.2021209.
4
Management of Simple Hepatic Cyst.
J Nippon Med Sch. 2022 Mar 11;89(1):2-8. doi: 10.1272/jnms.JNMS.2022_89-115. Epub 2021 Sep 14.
5
Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm.
Korean J Intern Med. 2021 Sep;36(5):1190-1203. doi: 10.3904/kjim.2020.634. Epub 2021 Jul 22.
6
Volumetric splenomegaly in patients with essential thrombocythemia and prefibrotic/early primary myelofibrosis.
Int J Hematol. 2021 Jul;114(1):35-43. doi: 10.1007/s12185-021-03121-x. Epub 2021 Mar 11.
7
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.
Am J Hematol. 2020 Dec;95(12):1599-1613. doi: 10.1002/ajh.26008. Epub 2020 Oct 23.
8
Physical activity can reduce the prevalence of gallstone disease among males: An observational study.
Medicine (Baltimore). 2020 Jun 26;99(26):e20763. doi: 10.1097/MD.0000000000020763.
9
Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms.
Blood Adv. 2019 Nov 26;3(22):3700-3708. doi: 10.1182/bloodadvances.2019000655.
10
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Am J Hematol. 2020 Feb;95(2):156-166. doi: 10.1002/ajh.25677. Epub 2019 Nov 29.
Zotero 插件